Masunori Matsuzaki

This inventor holds 14 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Cardiovascular Health. Top assignees: Mochida Pharmaceutical Co., Ltd., Yamaguchi University, Mochida Pharmaceutical., Ltd.. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masunori Matsuzaki. Retrieved from https://idiyas.com/inventor/masunori-matsuzaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 11)

% Patents Active = 78.6

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 309(Granted Patents)

Location History:

Yamaguchi, JP (2009 - 2016)
Ube, JP (2010 - 2020)

Company Filing History:

10 out of 229

Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical., Ltd.

Otsuka Pharmaceutical Company, Limited

patents

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

Areas of Expertise:

Cardiovascular Event

Stroke Prevention

Diabetes Reduction

Drug Delivery

Polypeptide

Calcium Leakage

Collagen Disorder

Elastin Metabolism

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10716775 - Composition for preventing the occurrence of cardiovascular event in multiple risk patient (2020-07-21),

2. 9700537 - Composition for preventing the occurrence of cardiovascular event in multiple risk patient (2017-07-11),

3. 9539230 - Composition for reducing new-onset diabetes (2017-01-10),

4. 9233093 - Composition and/or method for preventing recurrence of stroke (2016-01-12),

5. 9198892 - Composition and/or method for preventing onset and/or recurrence of cardiovascular events (2015-12-01),

6. 8853256 - Composition for preventing the occurrence of cardiovascular event in multiple risk patient (2014-10-07),

7. 8802718 - Composition for preventing the occurrence of cardiovascular event in multiple risk patient (2014-08-12),

8. 8529929 - Drug delivery system (2013-09-10),

9. 8367725 - Composition and/or method for preventing onset and/or recurrence of cardiovascular events (2013-02-05),

10. 8258183 - Composition and/or method for preventing recurrence of stroke (2012-09-04),

11. 7851589 - Polypeptide derived from the ryanodine receptor that inhibits calcium leakage (2010-12-14),

12. 7795308 - Composition and/or method for preventing recurrence of stroke (2010-09-14),

13. 7750033 - Preventive and remedy for collagen or elastin metabolic disorder (2010-07-06),

14. 7498359 - Composition and method for preventing recurrence of stroke (2009-03-03),

Title: Masunori Matsuzaki: Innovator in Cardiovascular Health

Introduction

Masunori Matsuzaki is a prominent inventor based in Yamaguchi, Japan. He has made significant contributions to the field of cardiovascular health, holding a total of 14 patents. His work focuses on developing compositions that aim to prevent cardiovascular events, particularly in patients with multiple risk factors.

Latest Patents

One of Matsuzaki's latest patents is a composition for preventing the occurrence of cardiovascular events in multiple risk patients. This innovative composition is designed to show a prophylactic effect on cardiovascular events occurring in hypercholesterolemia patients, even when they are undergoing treatment with HMG-CoA reductase inhibitors. This advancement is crucial for improving patient outcomes in cardiovascular health.

Career Highlights

Throughout his career, Matsuzaki has worked with notable organizations, including Mochida Pharmaceutical Co., Ltd. and Yamaguchi University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in cardiovascular health.

Collaborations

Matsuzaki has collaborated with esteemed colleagues such as Mitsuhiro Yokoyama and Hideki Origasa. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cardiovascular health.

Conclusion

Masunori Matsuzaki's contributions to cardiovascular health through his patents and collaborations highlight his dedication to improving patient care. His innovative compositions are paving the way for better prevention strategies in the field of cardiovascular medicine.

Profile summary based on public USPTO records.